4//SEC Filing
Sharpless Norman 4
Accession 0001562180-24-005085
CIK 0001560241other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:43 PM ET
Size
11.5 KB
Accession
0001562180-24-005085
Insider Transaction Report
Form 4
Sharpless Norman
Director
Transactions
- Award
Stock Options (Right to Buy)
2024-06-13+30,000→ 30,000 totalExercise: $2.99Exp: 2034-06-13→ Common Stock (30,000 underlying) - Award
Common Stock
2024-06-13+10,000→ 20,000 total
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors. The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 10,000 RSUs from award granted on June 15, 2023; and (ii) 10,000 RSUs from award granted on June 13, 2024.
- [F4]The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001940169
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:43 PM ET
- Size
- 11.5 KB